期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
氨噻唑头孢菌素Cefodizime 被引量:4
1
作者 朱汝锦 《国外医药(抗生素分册)》 CAS 北大核心 1992年第4期280-289,共10页
由德国赫斯特和法国罗赛尔公司合成开发的Cefodizime(HR221,CDZM),是一个较新的注射用亚氨甲氧基氨噻唑第三代头孢菌素。1981年赫斯特日本分公司和大鹏制药公司共同着手进行了基础临床研究,并于1990年3月在日本批准上市。CDZM结构与头... 由德国赫斯特和法国罗赛尔公司合成开发的Cefodizime(HR221,CDZM),是一个较新的注射用亚氨甲氧基氨噻唑第三代头孢菌素。1981年赫斯特日本分公司和大鹏制药公司共同着手进行了基础临床研究,并于1990年3月在日本批准上市。CDZM结构与头孢噻肟(CTX)、头孢唑肟(CZX)和头孢三嗪(CTRX)等相似,但在头孢烯核3′位上具有硫噻唑取代基。 展开更多
关键词 氨噻唑 头孢菌素 cefodizime
下载PDF
Effects of cefodizime on chemokines of liver tissues in mice with immunological hepatic injury 被引量:8
2
作者 WANG Peng KAN Quan-cheng +2 位作者 YU Zu-jiang LI Ling PAN Xue 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第5期746-750,共5页
Background Chronic hepatic inflammation is characterized by the accumulation of lymphocytes as a consequence of increased recruitment from the blood and retention within the tissue at sites of infection. CXC chemokine... Background Chronic hepatic inflammation is characterized by the accumulation of lymphocytes as a consequence of increased recruitment from the blood and retention within the tissue at sites of infection. CXC chemokine ligand 16 (CXCL16) mRNA has been detected in both inflamed and normal liver tissues and is strongly upregulated in the injured liver tissues in a murine model. The aim of this study was to investigate the effect of cefodizime on CXCL16 mRNA of liver tissues in mice with immunological hepatic injury.Methods The murine model of immunological hepatic injury was induced by Bacillus Calmette Guerin and Lipoposaccharide. The mice with immunological hepatic injury were randomly assigned to the model group, the cefodizime group and the ceftriaxone group. The three groups were continuously given agents for seven days and CXCL16 mRNA of liver tissue was determined and contrasted with the control group treated by normal saline. Reverse transcription-polymerase chain reaction was used to assay CXCL16 mRNA levels in liver tissues.Results The expressions of CXCL16 mRNA were significantly higher in the model group and the ceftriaxone group than in the control group and the cefodizime group (P〈0.05), indicating the mice in the model group and the ceftriaxone group were immunodeficient. There was no statistical difference in the expressions of CXCL16 mRNA between the control group and the cefodizime group. Similarly, no statistical difference in the expressions of CXCL16 mRNA between the model group and the ceftriaxone group was detected (P 〉0.05). Conclusion Cefodizime effectively reduces the infiltration of lymphocytes into liver tissues and alleviates the liver damage by decreasing CXCL16 rnRNA in liver tissues in mice with immunological hepatic injury. 展开更多
关键词 cefodizime immunological hepatic injury CHEMOKINE
原文传递
Nucleation and growth mechanism of cefodizime sodium at different solvent compositions 被引量:1
3
作者 Xinwei ZHANG Shudong ZHANG +4 位作者 Xiaodan SUN Zequn YIN Quanjie LIU Xiwen ZHANG Qiuxiang YIN 《Frontiers of Chemical Science and Engineering》 SCIE EI CAS CSCD 2013年第4期490-495,共6页
The induction time of cefodizime sodium was measured in ethanol-water at different solvent composi- tions by the laser technology measurement. The results indicate that the solvent composition played an important role... The induction time of cefodizime sodium was measured in ethanol-water at different solvent composi- tions by the laser technology measurement. The results indicate that the solvent composition played an important role in the supersaturation and the nucleation process of cefodizime sodium solution. According to the modified classical nucleation theory, the nucleation and growth mechanism were identified. The correlation results show that heterogeneous nucleation dominated the nucleation process at lower supersaturation, where homogeneous nucleation is the most important mechanism at higher supersaturation. Based on the correlated results, the 2D mediated growth mechanism had the highest correlation coefficients (R2), so this mechanism was selected as the proper growth mechanism for cefodizime sodium. 展开更多
关键词 cefodizime sodium induction time primarynucleation growth mechanism
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部